Indications and uses
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Loratadine, USP 10 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
If you have ever had an allergic reaction to this product or any of its ingredients.
Liver or kidney disease. Your doctor should determine if you need a different dose.
Do not take more than directed. Taking more than directed may cause drowsiness.
An allergic reaction to this product occurs. Seek medical help right away.
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
aspartame, croscarmellose sodium, fruit flavors, magnesium stearate, mannitol, sodium stearyl fumarate
Call 1-800-910-6874
NDC 11673-513-12
Original Prescription Strength
non-drowsy**
allergy relief
loratadine orally disintegrating tablets, 10 mg
antihistamine
indoor & outdoor allergies
Compare to active ingredient in Alavert®*
24 HOUR RELIEF
24-hour allergy relief of: sneezing/
runny nose/itchy nose and throat
no water needed/tablets melt in your mouth
for adults and children 6 years and older
mint flavor
**When taken as directed.
See drug facts panel.
up & up™
12 ORALLY DISINTEGRATING TABLETS
Distributed by Target Corporation
5079395/R1210

NDC 11673-527-31
Original Prescription Strength
non-drowsy**
allergy relief
loratadine orally disintegrating tablets,
10 mg antihistamine
indoor & outdoor allergies
Compare to active ingredient in Claritin®Reditabs®*
24-hour allergy relief of: sneezing/runny
nose/itchy, watery eyes/itchy throat or nose
no water needed/tablets melt in your mouth
for adults and children 6 years and older
**When taken as directed.
See drug facts panel.
up & up™
24 HOUR RELIEF
30 ORALLY DISINTEGRATING TABLETS
Distributed by Target Corp.
5079394/R1210

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11673-513-69 | 2021-01-29 | C162847 | 48780-1 | 9855d018-e840-cd31-e053-dbdaa90ab51a | Drug Facts |
| 11673-527-31 | 2021-01-29 | C162847 | 48780-1 | 9855d018-e840-cd31-e053-dbdaa90ab51a | Drug Facts |
| 11673-527-31 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e840-cd31-e053-dbdaa90ab51a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-513-69 | Loratadine | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 3 | |
| 11673-513-69 | Loratadine | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 3 | |
| 11673-527-31 | Loratadine | 30 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 30 | 3 | |
| 11673-527-31 | Loratadine | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-513 | LORATADINE TABLET, ORALLY DISINTEGRATING [TARGET CORPORATION] | 3 | Legacy NDC, 2 package rows | 20130424_e2fe073f-14da-424f-a34c-486d666fd649.zip |
| 11673-527 | LORATADINE TABLET, ORALLY DISINTEGRATING [TARGET CORPORATION] | 3 | Legacy NDC, 2 package rows | 20130424_e2fe073f-14da-424f-a34c-486d666fd649.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11673-513-12 | EA - Each | 11673-513 | e19c3043-000b-4d16-9272-d4dc3a241fe4 | 1 | 2013-02-13 |
| 11673-527-31 | EA - Each | 11673-527 | 33af7c96-b211-4509-8b3f-ad51e18e5655 | 1 | 2013-02-13 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LORATADINE | ACTIVE INGREDIENT | 7AJO3BO7QN | 3 | |
| LORATADINE | ACTIVE MOIETY | 7AJO3BO7QN | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 3 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11673-513 | 11673-513-69 |
| 11673-527 | 11673-527-31 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LORATADINE | 7AJO3BO7QN | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| SODIUM STEARYL FUMARATE | 7CV7WJK4UI | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| SODIUM STEARYL FUMARATE | 7CV7WJK4UI | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 78 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | POWDER, FOR SUSPENSION / ORAL | 11.25 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, FILM COATED / ORAL | 98 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / SUBCUTANEOUS | 4.54 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, ORALLY DISINTEGRATING / ORAL | 180 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SOLUTION / ORAL | 3767 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TROCHE / ORAL | 14594 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / ORAL | 869 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / OPHTHALMIC | 4.7 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / SUBMUCOSAL | 2.94 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION / SUBCUTANEOUS | 675 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | GRANULE, FOR SUSPENSION / ORAL | 6000 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 35 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SUSPENSION / ORAL | 7093 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | PELLET / ORAL | 43 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | GRANULE / ORAL | 1328 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 300 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | 180 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1568 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | SYRUP / ORAL | 0.63 mg/5ml | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | GRANULE, FOR SUSPENSION / ORAL | 420 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SPRAY / NASAL | 41.5 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CONCENTRATE / INTRAVENOUS | 220 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 181 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | LOZENGE / ORAL | 125 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, FILM COATED / ORAL | 330 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 113 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER / ORAL | 4352 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, FILM COATED / ORAL | 20 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / SUBCUTANEOUS | 99 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER / ORAL | 63 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | GRANULE, EFFERVESCENT / ORAL | 30 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, EXTENDED RELEASE / ORAL | 1086 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE / ORAL | 1562 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, DELAYED RELEASE / ORAL | 72 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | 195 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION/ DROPS / OPHTHALMIC | 4.6 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 105 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, DELAYED RELEASE / ORAL | 2043 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION, EXTENDED RELEASE / ORAL | 2464.6 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION / OPHTHALMIC | 9 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | WAFER / ORAL | 642 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, EXTENDED RELEASE / ORAL | 42 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET / SUBLINGUAL | 8 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, ORALLY DISINTEGRATING / ORAL | 153 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077153-001 | LORATADINE REDIDOSE | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 710cd931-0ca1-45b3-a430-14237c2365f4 | e2fe073f-14da-424f-a34c-486d666fd649 | 2012-10-05 | Warnings | 710cd931-0ca1-45b3-a430-14237c2365f4 e2fe073f-14da-424f-a34c-486d666fd649 |
Adverse event summaries are temporarily unavailable. Other product information remains available.